Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Feb 2021 11:00 AM
RNS
Price Monitoring Extension
15 Feb 2021 09:05 AM
RNS
Second Price Monitoring Extn
15 Feb 2021 09:00 AM
RNS
Price Monitoring Extension
03 Feb 2021 07:00 AM
RNS
Update on SCIB2 clinical development partnership
29 Jan 2021 07:00 AM
RNS
Interim Results for the 6 months ended 31 Oct 2020
30 Dec 2020 02:00 PM
RNS
Price Monitoring Extension
30 Dec 2020 11:05 AM
RNS
Second Price Monitoring Extn
30 Dec 2020 11:00 AM
RNS
Price Monitoring Extension
18 Dec 2020 04:41 PM
RNS
Second Price Monitoring Extn
18 Dec 2020 04:35 PM
RNS
Price Monitoring Extension
18 Dec 2020 02:05 PM
RNS
Second Price Monitoring Extn
18 Dec 2020 02:00 PM
RNS
Price Monitoring Extension
18 Dec 2020 07:00 AM
RNS
COVID-19 vaccine candidate selected
15 Dec 2020 03:45 PM
RNS
Director Dealing
14 Dec 2020 01:03 PM
RNS
Director Dealing
25 Nov 2020 11:26 AM
RNS
Director Dealing
17 Nov 2020 02:34 PM
RNS
Results of Annual General Meeting
17 Nov 2020 12:00 PM
RNS
Appointment of CMO and Medical Director
13 Nov 2020 12:36 PM
RNS
Director Dealing
10 Nov 2020 02:44 PM
RNS
Director Dealing
09 Nov 2020 02:06 PM
RNS
Second Price Monitoring Extn
09 Nov 2020 02:01 PM
RNS
Price Monitoring Extension
06 Nov 2020 11:49 AM
RNS
Holding(s) in Company
05 Nov 2020 10:51 AM
RNS
Result of Adjourned General Meeting
03 Nov 2020 08:33 AM
RNS
Holding(s) in Company
02 Nov 2020 05:00 PM
RNS
Convertible Loan Notes & Total Voting Rights
29 Oct 2020 10:15 AM
RNS
Result of Open Offer and Adjournment of GM
27 Oct 2020 04:41 PM
RNS
Second Price Monitoring Extn
27 Oct 2020 04:36 PM
RNS
Price Monitoring Extension
26 Oct 2020 10:10 AM
RNS
Conversion of Convertible Loan Notes
21 Oct 2020 04:12 PM
RNS
Notice of Annual General Meeting
16 Oct 2020 07:00 AM
RNS
Final Results for the year ended 30 April 2020
15 Oct 2020 11:10 AM
RNS
Holding(s) in Company
14 Oct 2020 11:36 AM
RNS
Holding(s) in Company
13 Oct 2020 12:07 PM
RNS
Posting of Circular
12 Oct 2020 07:00 AM
RNS
Proposed investment by Redmile and Open Offer
05 Oct 2020 07:00 AM
RNS
Notice of Final Results
02 Oct 2020 07:00 AM
RNS
Collaboration to manufacture COVID-19 vaccine
24 Sep 2020 07:00 AM
RNS
Directorate Change
14 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
14 Sep 2020 04:36 PM
RNS
Price Monitoring Extension
14 Sep 2020 09:05 AM
RNS
Second Price Monitoring Extn
14 Sep 2020 09:00 AM
RNS
Price Monitoring Extension
11 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
11 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
08 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
08 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
04 Sep 2020 07:00 AM
RNS
Director Award of Share Options
27 Aug 2020 07:00 AM
RNS
Funds awarded by Innovate UK for COVID-19 vaccine
26 Aug 2020 04:02 PM
RNS
Holding(s) in Company

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings